Trials / Unknown
UnknownNCT05425134
Deep Learning Signature for Predicting Occult Nodal Metastasis of Clinical N0 Lung Cancer
PET/CT-based Deep Learning Signature for Predicting Occult Nodal Metastasis of Clinical Stage N0 Non-Small Cell Lung Cancer: A Multicenter Prospective Diagnostic Trial
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 5,000 (estimated)
- Sponsor
- Shanghai Pulmonary Hospital, Shanghai, China · Academic / Other
- Sex
- All
- Age
- 20 Years – 75 Years
- Healthy volunteers
- —
Summary
The purpose of this study is to evaluate the performance of a PET/CT-based deep learning signature for predicting occult nodal metastasis of clinical stage N0 non-small cell lung cancer in a multicenter prospective cohort.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | PET/CT-based Deep Learning Signature | Deep Learning Signature Based on PET-CT for Predicting Occult Nodal Metastasis of Clinical N0 Non-small Cell Lung Cancer |
Timeline
- Start date
- 2022-01-01
- Primary completion
- 2023-12-31
- Completion
- 2023-12-31
- First posted
- 2022-06-21
- Last updated
- 2023-02-09
Locations
4 sites across 1 country: China
Source: ClinicalTrials.gov record NCT05425134. Inclusion in this directory is not an endorsement.